GI Module 8 | Lower GI Bleed

Welcome

Agent Colon Mucosal Epithelium

Student, stand with me inside the colon wall. I am a mucosal epithelial cell factory. I connect with neighboring epithelial cell factories through tight junctions and adhesion junctions to form epithelial tissue lining the colon.

Below me are connective tissue and small vessels. In this module, you will learn how vessel stress and fragility produce lower GI bleeding cues, and how perfusion-first actions protect tissue while source control is arranged.

Perfusion to colon mucosa and vasa recta

Agent Vasa Recta Endothelium

Student, I am a endothelial cell factory in a vasa recta vessel that passes through the colon wall. I connect with neighboring endothelial cell factories through tight junctions and adhesion junctions to form epithelial vessel lining. Smooth muscle cell factories around us form smooth muscle tissue that supports vessel tone.

In diverticular disease, vessel segments can become exposed and fragile. If pressure and mechanical stress rise, bleeding can begin. Perfusion decline can then spread risk to other tissues.

Agent Perfusion First

I teach the same sequence every time. Blood loss can lower preload, stroke volume, and MAP. Baroreceptors detect fall and sympathetic output rises. Norepinephrine stimulates beta-1 and alpha-1 pathways for temporary compensation, but source control is still required.

Pulling it together

When MAP stays stable, mucosa and vessel walls receive better ATP support and remain safer. When MAP trends down, tissue oxygen and glucose delivery fall. Cues such as dizziness, cool skin, and worsening weakness can appear.

Perfusion factor	Cell factory part	Tissue risk	Expected cue	Nursing action and why
MAP stability	Vasa recta wall endothelium	Lower shear injury risk	No active large-volume bleed cue	Monitor trend stability and maintain readiness, because deterioration can occur rapidly.
Volume loss	Systemic perfusion support chain	Global oxygen and glucose delivery drop	Cool skin, tachycardia, weakness, dizziness	Follow ordered volume support and escalate, because tissue ATP support is falling.
Recurrent slow loss	Fragile submucosal vascular bed	Persistent mucosal blood exposure	Maroon stool episodes and fatigue trend	Trend H and H, maintain IV readiness, and prepare for source localization, because intermittent loss can still decompensate.

Quick cue radar

Agent Perfusion First

Student, use one sequence. Identify cue. State tissue meaning. Take ordered action. Explain why that action protects perfusion and tissue.

Cue	Tissue meaning	Action	Why
Painless bright red stool	Possible diverticular vessel bleed	Two large-bore IVs, trend hemodynamics, prepare colonoscopy path	Protects perfusion and supports rapid source control readiness
Recurrent maroon stool	Possible angiodysplasia bleed pattern	Trend H and H, keep IV access, coordinate endoscopic cautery readiness	Intermittent loss still lowers oxygen delivery over time
MAP trending under 65 with cool skin	Perfusion decline risk	Follow ordered fluid and blood pathway, hold bowel prep until stable, escalate	Prevents worsening ATP failure and further instability

Lesson 1 - Colon wall and vessel cell factories

Agent Vasa Recta Endothelium

Student, I line the small vessels that feed colon tissue. When a diverticulum forms and wall geometry changes, parts of my vessel path can become vulnerable to injury and bleed.

Agent Colon Mucosal Absorber

I am a epithelial absorber cell factory. I connect with neighboring absorbers through tight junctions and adhesion junctions to form epithelial mucosal tissue. I absorb water and electrolytes. Blood on my surface changes stool color and pattern cues.

Pulling it together

Lower GI bleed cues are tissue outputs of cell-factory stress. You read stool pattern with perfusion data, then prioritize stabilization and source control readiness.

Layer	Cell factory focus	When stressed	Expected finding	Monitor and report
Mucosa	Absorber epithelial cells	Blood exposure and irritation	Bright red or maroon stool pattern	Stool amount, color change, frequency trend
Submucosa vascular bed	Endothelial cells and vessel support	Fragility and bleed episodes	Recurrent bleed cues with fatigue trend	H and H trend, hemodynamic trend, symptom progression
Muscular support region	Smooth muscle cells	Wall stress effects around diverticular outpouching	Potential vessel exposure risk	Trend escalation cues and procedure readiness

Micro-NGN check

Question 1. Which pattern best matches possible diverticular bleed?

Question 2. Why are trend sets better than isolated values?

Lesson 2 - Diverticular versus angiodysplasia pathways

Agent Submucosal Vessel Wall

Student, in diverticular bleeding, exposed vessel segments near outpouchings can rupture. In angiodysplasia, fragile vascular lesions can bleed intermittently. Both can produce lower GI blood cues, but pattern and recurrence differ.

Feature	Diverticular path	Angiodysplasia path
Typical pattern	Sudden bright red bleed, often painless	Intermittent maroon bleed, often recurrent
Tissue issue	Exposed or eroded vessel near diverticulum	Fragile vascular malformation bleed points
Urgent priorities	Perfusion support, source localization, endoscopic control readiness	Perfusion support, trend monitoring, cautery or endoscopic therapy planning
Labs and prep	CBC, H and H trend, type and cross in active bleed context	CBC and trend tracking for chronic or intermittent loss burden

Pulling it together

Do not delay perfusion support waiting for perfect source certainty. Stabilize first, trend continuously, and coordinate diagnostic and therapeutic endoscopy safely.

Micro-NGN check

Question 1. Which recurring pattern raises angiodysplasia concern?

Question 2. Why maintain type and cross readiness in active lower GI bleeding?

Lesson 3 - NGN case: lower GI bleed progression

Agent Perfusion First

Student, case snapshot. Patient has bright red stool, pulse rising, MAP 64, cool skin, and weakness. This pattern signals active loss with perfusion risk.

Pulling it together with NCJMM

Recognize cues: stool blood pattern, MAP trend, pulse trend, skin perfusion and mentation cues.

Analyze cues: likely lower GI source with evolving volume-loss physiology.

Prioritize hypotheses: active lower GI bleed with compensation strain.

Generate solutions: two large-bore IV access, ordered fluid or blood pathway, hold bowel prep until stable, source-control planning.

Take actions: follow urgent orders, monitor trend sets, escalate early.

Evaluate outcomes: MAP rises above target, pulse trends down, skin warms, bleeding burden reduces.

Action	Nursing consideration	Why
Two large-bore IV lines	Confirm patency and secure access	Enables fast ordered volume and blood support
Fluid or blood per order	Monitor pressure and overall tolerance trends	Supports preload and MAP recovery
Hold bowel prep when unstable	Reassess perfusion before prep sequence	Avoids worsening hypotension risk
Trend labs and hemodynamics	Use serial interpretation, not single values	Detects deterioration early and supports escalation

Micro-NGN check

Question 1. Which immediate priority best matches MAP 64 with active lower GI blood loss?

Question 2. Which trend set suggests improvement?

Lesson 4 - Medications, procedures, and teaching

Agent Vascular Smooth Muscle Cell

Student, sympathetic signaling can help short-term compensation through alpha-1 pathways, but bleeding source control is still required. Pharmacology and procedures must be tied to tissue protection and perfusion restoration.

Pulling it together: treatment logic

During active lower GI bleeding, support ordered fluids and blood products, maintain access, and prepare endoscopic source control.

Avoid NSAIDs after bleed unless specifically directed, because re-bleed risk can rise.

If upper source is not ruled out, ordered acid-suppression strategy may still be used by team plan.

Antibiotics are not routine for simple bleed. They are considered when infection-related pathology, such as diverticulitis, is present by diagnosis and orders.

Item	Primary purpose	What to monitor and report
Crystalloid or blood products per order	Restore volume, oxygen delivery, and perfusion stability	MAP and pulse trend, skin perfusion, mentation, ongoing stool blood trend
Endoscopic therapy planning	Clip or cauterize bleeding vessel source	Pre-procedure readiness, post-procedure recurrent bleed cues
NSAID avoidance teaching	Reduce recurrent mucosal and vascular injury risk	Understanding, adherence, safer pain-plan reinforcement
Bowel prep timing	Prepare visualization when hemodynamically safe	Do not proceed while unstable perfusion trends persist

Micro-NGN check

Question 1. Why may bowel prep be delayed in active lower GI bleeding with low MAP?

Question 2. Which discharge teaching point is highest priority?

Core flashcards

Front: Painless bright red stool suggests?

Back: Diverticular bleeding is a common concern. Stabilize perfusion and prepare source-control pathway.

Front: Recurrent maroon stool suggests?

Back: Angiodysplasia is a common recurrent pattern consideration.

Front: Why perfusion before bowel prep?

Back: Prep can worsen hypotension when MAP is unstable. Stabilize first.

Front: Two large-bore IVs matter because?

Back: High-flow access supports urgent ordered fluids and blood products.

Front: Why trend sets over single values?

Back: Trend clusters detect decompensation earlier than isolated readings.

Front: LPN focus language?

Back: Monitor, collect trends, follow orders, reinforce teaching, and report deterioration early.

Safety first checklist

Check perfusion first in all lower GI bleed scenarios.
Maintain two large-bore IV lines when active bleed risk is present.
Follow ordered fluids and blood support promptly while tracking response.
Hold bowel prep when unstable and resume only when ordered and hemodynamically safer.
Trend and report MAP, pulse, skin perfusion, mentation, stool blood pattern, and lab trends.

Rapid handoff script

I am reporting ____.
The trend is ____.
My tissue concern is ____.
Current perfusion concern is ____.
Orders in progress are ____.
I need review now because ____.